Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
10.1182/blood-2012-03-415307
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2016
|
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/128647 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-128647 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1286472023-10-29T20:33:50Z Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation Cortes, J. Lipton, J.H. Rea, D. Digumarti, R. Chuah, C. Nanda, N. Benichou, A.-C. Craig, A.R. Michallet, M. Nicolini, F.E. Kantarjian, H. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE 10.1182/blood-2012-03-415307 Blood 120 13 2573-2580 BLOOA 2016-10-19T08:43:35Z 2016-10-19T08:43:35Z 2012-09-27 Article Cortes, J., Lipton, J.H., Rea, D., Digumarti, R., Chuah, C., Nanda, N., Benichou, A.-C., Craig, A.R., Michallet, M., Nicolini, F.E., Kantarjian, H. (2012-09-27). Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation. Blood 120 (13) : 2573-2580. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2012-03-415307 00064971 http://scholarbank.nus.edu.sg/handle/10635/128647 000311615800011 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| description |
10.1182/blood-2012-03-415307 |
| author2 |
DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
| author_facet |
DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Cortes, J. Lipton, J.H. Rea, D. Digumarti, R. Chuah, C. Nanda, N. Benichou, A.-C. Craig, A.R. Michallet, M. Nicolini, F.E. Kantarjian, H. |
| format |
Article |
| author |
Cortes, J. Lipton, J.H. Rea, D. Digumarti, R. Chuah, C. Nanda, N. Benichou, A.-C. Craig, A.R. Michallet, M. Nicolini, F.E. Kantarjian, H. |
| spellingShingle |
Cortes, J. Lipton, J.H. Rea, D. Digumarti, R. Chuah, C. Nanda, N. Benichou, A.-C. Craig, A.R. Michallet, M. Nicolini, F.E. Kantarjian, H. Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
| author_sort |
Cortes, J. |
| title |
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
| title_short |
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
| title_full |
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
| title_fullStr |
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
| title_full_unstemmed |
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
| title_sort |
phase 2 study of subcutaneous omacetaxine mepesuccinate after tki failure in patients with chronic-phase cml with t315i mutation |
| publishDate |
2016 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/128647 |
| _version_ |
1781790586986037248 |